News

Study Answers Important Question about Using Carbon Nanotubes in Medicine

A multicenter study led by Memorial Sloan Kettering researchers has answered an important question about the safety of using carbon nanotubes in medicine.

Friday, October 1, 2010
Pictured: Eric C. Holland
Researchers Discover Genetic Changes That Make Some Forms of Brain Cancer More Aggressive Than Others

A multi-institutional team led by investigators from Memorial Sloan Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies.

Friday, October 1, 2010
2010 Shaps Scholars

Four summer students — Jeannie Camarillo, Emily Grzybowski, Nathaniel Kim, and Daniel Triner — were named 2010 Rubin and Sarah Shaps Scholars.

Wednesday, September 1, 2010
A Decade of Leadership

Harold Varmus became President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center on January 1, 2000. He ended his decade-long tenure on July 1, 2010. And on July 12, 2010, Dr. Varmus took up a new role as Director of the National Cancer Institute.

Thursday, July 1, 2010
Ingo Mellinghoff
Researchers Uncover Molecular Interactions in Common Form of Brain Cancer

A multicenter team led by Memorial Sloan Kettering neurologist and researcher Ingo K. Mellinghoff has uncovered the relationship between two proteins that play a critical role in glioblastoma, the most common form of brain cancer.

Thursday, July 1, 2010
Inherited Mutations May Point to an Aggressive Form of Prostate Cancer

A team of Memorial Sloan Kettering researchers reports that prostate cancer often takes an aggressive course in patients who have inherited mutations in the genes BRCA1 or BRCA2.

Thursday, July 1, 2010
Boris Bastian Named Chair of the Department of Pathology

Physician-scientist Boris C. Bastian joined Memorial Sloan Kettering as Attending Physician and Chair of the Department of Pathology on April 1.

Thursday, July 1, 2010
Large-Scale Genomic Analysis of Prostate Cancer Unveiled

A unique collaboration among physician-scientists at Memorial Sloan Kettering Cancer Center has yielded the most comprehensive genomic analysis of prostate cancer to date. The study, published in the journal Cancer Cell, provides a previously unavailable genomic analysis whose scope and size offers new insight leading to more effective diagnostic tests as well as future treatment options for prostate cancer patients.

Thursday, June 24, 2010
Circulating Tumor Cells May Spur Cancer by a Previously Unknown Mechanism

A recent Memorial Sloan Kettering study shows that some circulating tumor cells can circle back and infiltrate their tumor of origin, enhancing its growth and aggressiveness.

Tuesday, June 1, 2010
Joan Massagué leads Memorial Sloan Kettering's Metastasis Research Center
Opening Cancer's Black Box

The Metastasis Research Center has brought together 27 Memorial Sloan Kettering laboratories to facilitate research on metastasis and its treatment.

Tuesday, June 1, 2010